Literature DB >> 24930457

Improving long-term outcomes of kidney transplantation: The pressure is on.

D A Hesselink1, E J Hoorn.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24930457

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


× No keyword cloud information.
  5 in total

1.  Factors Affecting Time-Varying Clearance of Cyclosporine in Adult Renal Transplant Recipients: A Population Pharmacokinetic Perspective.

Authors:  Xiaoyan Qiu; Weiwei Qin; Junjun Mao; Luyang Xu; Ming Zhang; Mingkang Zhong
Journal:  Pharm Res       Date:  2021-11-08       Impact factor: 4.200

2.  A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.

Authors:  Louise M Andrews; Dennis A Hesselink; Teun van Gelder; Birgit C P Koch; Elisabeth A M Cornelissen; Roger J M Brüggemann; Ron H N van Schaik; Saskia N de Wildt; Karlien Cransberg; Brenda C M de Winter
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

3.  A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.

Authors:  L M Andrews; D A Hesselink; R H N van Schaik; T van Gelder; J W de Fijter; N Lloberas; L Elens; D J A R Moes; B C M de Winter
Journal:  Br J Clin Pharmacol       Date:  2019-01-17       Impact factor: 4.335

4.  Highly sensitive and rapid determination of tacrolimus in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.

Authors:  Soma Bahmany; Lucia E A de Wit; Dennis A Hesselink; Teun van Gelder; Nauras M Shuker; Carla Baan; Bart C H van der Nagel; Birgit C P Koch; Brenda C M de Winter
Journal:  Biomed Chromatogr       Date:  2018-11-14       Impact factor: 1.902

5.  A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement.

Authors:  Louise M Andrews; Brenda C M de Winter; Elisabeth A M Cornelissen; Huib de Jong; Dennis A Hesselink; Michiel F Schreuder; Roger J M Brüggemann; Teun van Gelder; Karlien Cransberg
Journal:  Clin Pharmacokinet       Date:  2020-05       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.